Cardiocore Consortium Wins 10-Year, $20B National Institutes of Health Contract
09.July.2012; Washington, DC-Cardiocore, a premier centralized cardiac testing laboratory and technology provider, announced today that its consortium has been awarded the coveted Chief Information Officer-Solutions and Partners 3 (CIO-SP3) Government Wide Acquisition Contract (GWAC). This contract, sponsored by the National Institutes of Health (NIH), is valued at $20 billion over a 10-year term.
Led by Creative Information Technology (CITI), Cardiocore’s team also includes ICON Medical Imaging and Zimmerman Associates (ZAI). These organizations are joined through a Contractor Team Agreement (CTA). In total, the NIH’s CIO-SP3 indefinite delivery/indefinite quantity (ID/IQ) program comprises approximately 50 contractors, serving a wide range of government agencies, with particular focus on Biomedical Research, Health Sciences, and Healthcare work orders.
"We are very pleased that our team has been selected by the NIH for this landmark CIO-SP3 award," said Scott Satin, Cardiocore’s Vice President of Marketing. "We look forward to expanding our NIH and other government-sponsored services in the decade ahead, and we are delighted to be part of such a well-qualified, well-experienced coalition."
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Patient Engagement Platform Checklist
November 22nd 2024Modern clinical trials are more complex than ever, and one significant reason is the increased focus on patient engagement. Incorporating a patient engagement platform into your clinical trial enhances the patient experience and can lead to more successful trials with stronger, more reliable outcomes. We put together this helpful checklist of key features to look out for when choosing a platform for your study.
